Endocannabinoid signaling pathways: beyond CB1R and CB2R

被引：21
|
作者：
Biringer, Roger Gregory [1 ]
机构：
[1] Lake Erie Coll Osteopath Med, Coll Osteopath Med, Bradenton, FL 34211 USA
来源：
JOURNAL OF CELL COMMUNICATION AND SIGNALING | 2021年 / 15卷 / 03期
关键词：
Anandamide; 2-Acyl glycerol; Endocannabinoid; Phytocannabinoid; Cannabinoid; N-ARACHIDONOYL GLYCINE; COUPLED RECEPTOR 18; LYSOPHOSPHATIDIC ACID RECEPTOR; ROSTRAL VENTROLATERAL MEDULLA; GLUCAGON-LIKE PEPTIDE-1; CANNABINOID RECEPTORS; PANCREATIC BETA; HIGH-AFFINITY; CYCLIC-AMP; SPHINGOSINE; 1-PHOSPHATE;
D O I：
10.1007/s12079-021-00622-6
中图分类号：
Q2 [细胞生物学];
学科分类号：
071009 ; 090102 ;
摘要：
The search for cannabinoid receptors other than CB1R and CB2R has been ongoing for over a decade. A number of orphan receptors have been proposed as potential cannabinoid receptors primarily based on phylogenic arguments and reactivity towards known endocannabinoids and phytocannabinoids. Seven putative cannabinoid receptors are described and discussed, and evidence for and against their inclusion in this category are presented.
引用
收藏
页码：335 / 360
页数：26
相关论文
共 50 条
  • [41] CB2R ACTIVITY INHIBITION LINKED TO CIDS REVERSAL IN MICE
    Christian, L.
    Burkovskiy, I.
    Zhou, J.
    ANESTHESIA AND ANALGESIA, 2016, 122
  • [42] The therapeutic potential of second and third generation CB1R antagonists
    Cinar, Resat
    Iyer, Malliga R.
    Kunos, George
    PHARMACOLOGY & THERAPEUTICS, 2020, 208
  • [43] CB1R类减肥药物研发受挫
    Dan Jones
    黄艳
    中国处方药, 2008, (12) : 8 - 8
  • [44] CANNABINOL AMELIORATES SYSTEMIC INFLAMMATION THROUGH CNS CB1R
    Lloyd, Elliot
    Yeh, Che-Chung
    Tsutsui, Kyle
    Xu, Fengyun
    Hellman, Judith
    SHOCK, 2024, 62 (01): : 63 - 63
  • [45] The progress of small molecules against cannabinoid 2 receptor (CB2R)
    Zhang, Qinying
    Zhao, Ying
    Wu, Jianan
    Zhong, Wanting
    Huang, Wenhai
    Pan, Youlu
    BIOORGANIC CHEMISTRY, 2024, 144
  • [46] Cannabinoid receptor 1 (CB1R) expression in rat dental pulp
    Mitrirattanakul, Somsak
    Poomsawat, Sopee
    Fuangtharnthip, Pornpoj
    ORAL SCIENCE INTERNATIONAL, 2012, 9 (01) : 17 - 20
  • [47] Effects of the CB1R agonist WIN-55,212-2 and the CB1R antagonists SR-141716 and AM-1387:: Open-field examination in rats
    Jarbe, T. U. C.
    Ross, T.
    DiPatrizio, N. V.
    Pandarinathan, L.
    Makriyannis, A.
    PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 2006, 85 (01) : 243 - 252
  • [48] Stratification of Cannabinoid 1 Receptor (CB1R) Agonist Efficacy: Manipulation of CB1R Density through Use of Transgenic Mice Reveals Congruence between In Vivo and In Vitro Assays
    Grim, T. W.
    Morales, A. J.
    Gonek, M. M.
    Wiley, J. L.
    Thomas, B. F.
    Endres, G. W.
    Sim-Selley, L. J.
    Selley, D. E.
    Negus, S. S.
    Lichtman, A. H.
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2016, 359 (02): : 329 - 339
  • [49] Cannabinoid receptor interacting protein (CRIP1a) attenuates CB1R signaling in neuronal cells
    Blume, Lawrence C.
    Eldeeb, Khalil
    Bass, Caroline E.
    Selley, Dana E.
    Howlett, Allyn C.
    CELLULAR SIGNALLING, 2015, 27 (03) : 716 - 726
  • [50] Design, Synthesis, and SAR Studies of Heteroarylpyrimidines and Heteroaryltriazines as CB2R Ligands
    Qian, Hai-Yan
    Wang, Zhi-Long
    Chen, Li-Li
    Pan, You-Lu
    Xie, Xiao-Yu
    Xie, Xin
    Chen, Jian-Zhong
    CHEMMEDCHEM, 2018, 13 (22) : 2455 - 2463
12345